InstituteOfScience.com
Copyright 1995-2001 S.H. Shakman, Institute Of Science; all
rights reserved.
AUTOHEMOTHERAPY EXERPTS - INDEX TO SUBJECTS
[AUTOHEMOTHERAPY, unless noted as AUTOSERO or GILBERT'S METHOD]
GO TO REFERENCE LIST
ACCIDENTAL CURE AS AUTOHEMOTHERAPY - 32H1
AMA ENDORSEMENTS
- AUTOHEMOTHERAPY FOR PSORIASIS: JAMA
111, 1938, p. 343
- AUTOSEROTHERAPY [GILBERT'S METHOD] FOR SEROFIBRINOUS PLEURISY:
JAMA, April 18, 1915
ANTICOAGULANTS DENOUNCED 38A16
AUTOHEMIC SERUM: "CURE FOR LAZINESS, UGLINESS, FRIGITIDY" 23E1
AUTOHEMIC TAKE TWO - 49H2
GO TO REFERENCE LIST
BENEFICIAL EFFECT OF OTHER DISEASES ON MENTAL ILLNESS 51C11
BENEFIT OF REPEATED SMALL TRANSFUSIONS, PERNICIOUS ANEMIA - 17H1
BLOOD, EFFECT OF AUTOHEMO- ON - 13E11,
25H1
BLOOD AND MIND IN HISTORY 51C11
GO TO REFERENCE LIST
CHOLESTEROL IN CARDIOPATHY PATIENTS, AFTER AUTOHEMO 95G1
CITRATED BLOOD
-DANGER: TRANSFUSIONS -Unger 1916; SUBCONJUNCTIVAL - 65F1
--IN AUTOHEMOTHERAPY, DENOUNCED 23E6 PER DEAN [38A16, 784
--VS HEPARIN & CACL2, AND OZONIZATION 93G2
GO TO REFERENCE LIST
CONVALESCENT BLOOD, IM - 17H1
COST - 57C3
CRITIC [AUTOSERO-] CONVERTED TO ADVOCATE AUTOHEMIC - 31H1
CRITICIZED [AUTOSERO-] [31H1]
CURE FOR ALL DISEASES - 24E8
GO TO REFERENCE LIST
DANGER OF CITRATED BLOOD, SUBCONJUNCTIVAL AUTOHEMO- 65F1
DOSAGE - 24E3, 41A6, 38B2 (LARGE IN INFECTIOUS
CONDITIONS)
GO TO REFERENCE LIST
EXPLANATION/MODE OF ACTION/THEORY - 37B3
--ACTION LIKENED TO HISTAMINE - 49A2
--ADRENAL CORTEX, THEORIZED ROLE OF 51C7
--AS BLOODLETTING [AUTOSERO-] - 14H3
--AS DESENSITIZATION - 33B10, 24E1
--AS NON-SPECIFIC THERAPY - 31H1
--AS SPECIFIC THERAPY - 55C2
--AS "VACCINE" (I.M.) - 17H1
--AS VACCINETHERAPY - [AUTOSERO-] 17A1
--AS VENESECTION? [AUTOSERO-] - 14H2
GO TO REFERENCE LIST
--BENEFIT NOT DUE TO "PASSIVE" MECHANISM [AUTOSERO-] - 17A1
--BY PROCESS OF ELIMINATION - 32A1
--COMPELS PRODUCTION OF ANTIBODY - 13H2
--EFFECT OF EXTERIORIZATION OF BLOOD 38A6
--EXTERIORIZATION AS SUSPECTED MECHANISM [AUTOSERO-] 14H3
--HEMOCLASTIC SHOCK, LIKENED TO - 24E3
--NOT IMPORTANT W/FAVORABLE RESULT - 35A14
--NOT PROTEIN SHOCK THERAPY 38B2
GO TO REFERENCE LIST
FAILURE [AUTOSERO-] - 16H5
FREQUENCY OF INJECTION - 24E3, 16H3 [AUTOSERO]
GO TO REFERENCE LIST
HEPARIN & CACL2 VS CITRATED BLOOD, AND OZONIZATION 93G2
GO TO REFERENCE LIST
I.M. VS. I.V. - 17H1 [SERUM OR BLOOD], 16H6 [AUTOSERO]
INITIAL SKEPTICISM OF ONE CONVERT [AUTOSERO-]- 14H3
IRRADIATION AND AUTOHEMO - SYPHILLIS 37B25
IRRADIATION NOT NECESSARY 49H1
IV WITH HEMOLYSED BLOOD, AND MALARIA THERAPY 38A16
LENGTH OF SERIES 24E3
GO TO REFERENCE LIST
MALARIA THERAPY 37B25, 32H1, 38A16
MALARIA THERAPY, IV AUTOHEMO- WITH HEMOLYSED BLOOD AND 38A16
MEDICINE, AUTOBLOOD AS OLD AS 35A1
METHOD 60H1, 24E3,
14H2 [AUTOSERO], 14H3 [AUTOSERO]
GO TO REFERENCE LIST
OZONIZATION AND: CITRATED BLOOD VS HEPARIN & CACL2 93G2
GO TO REFERENCE LIST
PREDICTION OF LOWER MORTALITY WHEN AUTOHEMO- POPULAR 38B2
PROPHYLACTISM FOR ALL DISEASES - 24E8
PYOTHERAPY (PUS) 37B25
PYROTHERAPY (HEAT) - 32H1
GO TO REFERENCE LIST
RECOMMENDED WHERE FEVER THERAPY IS CONTRAINDICATED - 37B25
RESULTS - 24E3, 25A26, 60H1, 33B10; 14H2 [AUTOSERO-], 14H3 [AUTOSERO-], 17A1
[AUTOSERO-]
GO TO REFERENCE LIST
SAFETY
--AUTOHEMOTHERAPY: 17H1 [I.M. VS. I.V.],
32H1, 37B3, 55C2, 57C3, 38A6, 37B25
--AUTOSEROTHERAPY: 14H2, 14H3, 17A1, 21A2, 32H1
--GILBERT METHOD: 15H1
SPIETHOFF'S RELUCTANCE TO GRANT PRIORITY TO RAVAUT - 13E7
GO TO REFERENCE LIST
TECHNIC - 24E1, 38B2, 37B3, 55C2, 57C3
THEORY 51C11; see also EXPLANATION above
GO TO REFERENCE LIST
VACCINETHERAPY, DANGERS OF OVERDOSAGE WITH 49H1
VENESECTION IS VACCINETHERAPY 17A1
VENESECTION, AND AUTOHEMO- 38B2
GO TO REFERENCE LIST
WHY LOST - 49H2; see Lederberg 1988,
Dowling 1977
GO TO REFERENCE LIST